| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 44.819 | 60.168 | 132.639 | 170.009 | 187.595 | 214.885 |
| Total Income - EUR | - | - | - | - | 44.819 | 60.168 | 133.591 | 174.071 | 194.893 | 214.884 |
| Total Expenses - EUR | - | - | - | - | 11.035 | 23.828 | 61.116 | 103.554 | 127.470 | 153.826 |
| Gross Profit/Loss - EUR | - | - | - | - | 33.785 | 36.340 | 72.475 | 70.517 | 67.423 | 61.058 |
| Net Profit/Loss - EUR | - | - | - | - | 32.440 | 34.655 | 71.331 | 68.817 | 65.547 | 54.611 |
| Employees | - | - | - | - | 1 | 1 | 2 | 4 | 4 | 4 |
Check the financial reports for the company - Neuro. Vidry S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 12.802 | 230.810 | 222.428 | 236.689 | 332.311 | 544.017 |
| Current Assets | - | - | - | - | 20.258 | 10.178 | 42.226 | 61.955 | 25.955 | 16.578 |
| Inventories | - | - | - | - | 36 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 6.928 | 4.382 | 16.231 | 55.607 | 19.502 | 203 |
| Cash | - | - | - | - | 13.294 | 5.796 | 25.994 | 6.348 | 6.453 | 16.375 |
| Shareholders Funds | - | - | - | - | 32.482 | 34.705 | 71.379 | 68.893 | 65.596 | 54.659 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 578 | 206.283 | 193.275 | 229.751 | 292.670 | 505.936 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuro. Vidry S.r.l.